Terbinafine | Exeter Tablets 250 mg, 14 pcs.

Latin name

Exiter

release form

tablets



packaging 14 pcs

Indications

Fungal lesions of the skin, nails and hair, candidiasis of the skin and mucous membranes.

Contraindications

Hypersensitivity, severe hepatocellular and renal failure, blood diseases, tumors, metabolic diseases, vascular pathology of the extremities, pregnancy, breast-feeding, children (up to 2 years).

Composition

1 tablet contains:

Active ingredient: terbinafine hydrochloride 281 mg, calculated on terbinafine 250 mg

Excipients: microcrystalline cellulose, sodium starch glycolate, starch gelatinized starch, silica gelatinized.

Dosage and administration of

Inside adults - 250 mg / day in 1 or 2 doses. The duration of treatment depends on the indications and severity of the infection: for skin lesions - 2-4 weeks, for nail damage - from 6 weeks to 4 months or more. For children weighing more than 40 kg - 250 mg / day, 20-40 kg - 125 mg / day, up to 20 kg - 62.5 mg / day.

Topically applied 1-2 times a day for 1-2 weeks.

Side effects of the

Digestive system: nausea, anorexia, moderate abdominal pain, diarrhea, disturbance or loss of taste, cholestasis, jaundice, hepatitis.

Allergic reactions: skin rash rarely - arthralgia, myalgia, erythema multiforme, Stevens-Johnson syndrome.

From the side of the central nervous system: headache.

From the hemopoietic system: neutropenia, thrombocytopenia.

Local reactions: hyperemia, itching, burning sensation.

Storage conditions

In the dark place at a temperature of no higher than 25 РC. Do not freeze.

Term hodnosty

3 years

Active ingredient

Terbinafine

PMA

tablets

Ozon, Russia